Remdesivir Global Market Report 2025

Description

Remdesivir, classified as an antiviral drug, is utilized in the treatment of hospitalized adults and children aged 28 days and older, weighing at least 6.6 pounds, for the management of COVID-19 disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. It is specifically recommended for individuals at significant risk of developing severe COVID-19, potentially leading to hospitalization or fatal outcomes.

The primary routes of administering remdesivir are oral and intravenous. Intravenous administration involves delivering the drug or substance directly into a vein using a syringe or tubing. Remdesivir is available in various dosage forms such as tablets, frozen solutions, and lyophilized solutions. These medications are distributed through diverse channels including hospitals, clinics, drug stores or pharmacies, online platforms, and other relevant healthcare avenues.

The remdesivir market research report is one of a series of new reports from The Business Research Company that provides remdesivir market statistics, including remdesivir industry global market size, regional shares, competitors with a remdesivir market share, detailed remdesivir market segments, market trends and opportunities, and any further data you may need to thrive in the remdesivir industry. This Remdesivir market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The remdesivir market size has grown exponentially in recent years. It will grow from $6.49 billion in 2024 to $8.52 billion in 2025 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to increasing prevalence of COVID-19, rising awareness of remdesivir, government support for remdesivir, clinical trials and research, government purchases.

The remdesivir market size is expected to see rapid growth in the next few years. It will grow to $15.91 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to ongoing COVID-19 response, emerging variants, global vaccination campaigns, pandemic preparedness, global health initiatives. Major trends in the forecast period include personalized medicine, combination therapies, production scalability, telemedicine and remote monitoring, research on new indications, alternative antiviral therapies.

Rising government expenditure is anticipated to drive the expansion of the remdesivir market. This form of spending, encompassing funds directed by the government toward operations, programs, and services, plays a pivotal role in fostering the accessibility and growth of Remdesivir, particularly in times of public health crises. By allocating resources, providing regulatory support, and investing in research, governments contribute significantly to enhancing the availability and affordability of this critical antiviral medication. For instance, in July 2023, the UK government increased its spending on services and capital projects, thereby contributing to the market's growth.

The escalating demand for clinical trials and research is poised to fuel the remdesivir market. These systematic investigations in healthcare evaluate the safety and efficacy of medical interventions, including Remdesivir's effectiveness in treating viral infections like COVID-19. These trials yield vital scientific evidence regarding the drug's impact on symptom severity, duration, and safety. For instance, as of May 2023, there has been a notable increase in registered clinical studies, indicating a growing need for research and trials. This surge in demand underscores the driving force behind the market's growth.

Major companies in the remdesivir market are obtaining FDA approvals for new drugs, such as Veklury (Remdesivir), to bolster their market position. Veklury, approved by the FDA in January 2022, serves as an antiviral medication specifically designed to treat mild to moderate COVID-19 symptoms in adults and children. This strategic move by companies like Gilead Sciences Inc. contributes to their profitability and market dominance.

Leading companies in the remdesivir market are forming partnerships to enhance their profitability. For example, in July 2022, Gilead Sciences, a US-based biopharmaceutical company focused on antiviral therapies, entered into a new joint procurement agreement with the European Commission. This partnership was intended to optimize the distribution of its antiviral treatments, including Remdesivir, to European member states, ensuring that essential medications are delivered in a timely manner. The European Commission serves as the executive body of the European Union and is based in Belgium.

In February 2023, Kite Pharma, a US-based biotechnology firm, completed the acquisition of Tmunity Therapeutics Inc for an undisclosed sum. This strategic move is aimed at granting Kite access to a range of pre-clinical and clinical initiatives, as well as efficient production techniques. Notably, the acquisition includes access to Tmunity's 'armored' CAR T technology platform, which holds promise for enhancing the effectiveness of various CAR T therapies against tumors.

Major companies operating in the remdesivir market include Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Pfizer Inc., Merck & Co. Inc., Cayman Chemical Company, Dr Reddy's Laboratories Ltd., Inovio Pharmaceuticals, Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Berry Global Group, Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories

North America was the largest region in the remdesivir market in 2024. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in the remdesivir market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the remdesivir market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The remdesivir market consists of sales of nucleotide analogue and Veklury. Values in this market are 'factory gate values,' that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Remdesivir Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on remdesivir market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for remdesivir ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The remdesivir market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Route Of Administration: Oral; Intravenous
2) By Dosage Form: Tablets; Frozen Solution; Lyophilized Solution
3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Other Distribution Channels
Subsegments:
1) By Oral: Tablet Formulation; Liquid Formulation
2) By Intravenous: Ready-To-Use Injectable; Lyophilized Powder For Injection
Companies Mentioned: Gilead Sciences Inc.; BrightGene Bio-Medical Technology Co Ltd; Hainan Haiyao Co. Ltd.; Sichuan Kelun Pharmaceutical Co. Ltd.; Hunan Warrant Pharmaceutical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32965

1. Executive Summary

2. Remdesivir Market Characteristics

3. Remdesivir Market Trends And Strategies

4. Remdesivir Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Remdesivir Growth Analysis And Strategic Analysis Framework

5.1. Global Remdesivir PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Remdesivir Market Growth Rate Analysis
5.4. Global Remdesivir Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Remdesivir Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Remdesivir Total Addressable Market (TAM)

6. Remdesivir Market Segmentation

6.1. Global Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
6.2. Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Frozen Solution
Lyophilized Solution
6.3. Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Drug Stores/Pharmacies
Online
Other Distribution Channels
6.4. Global Remdesivir Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablet Formulation
Liquid Formulation
6.5. Global Remdesivir Market, Sub-Segmentation Of Intravenous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ready-To-Use Injectable
Lyophilized Powder For Injection

7. Remdesivir Market Regional And Country Analysis

7.1. Global Remdesivir Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Remdesivir Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Remdesivir Market

8.1. Asia-Pacific Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Remdesivir Market

9.1. China Remdesivir Market Overview
9.2. China Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Remdesivir Market

10.1. India Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Remdesivir Market

11.1. Japan Remdesivir Market Overview
11.2. Japan Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Remdesivir Market

12.1. Australia Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Remdesivir Market

13.1. Indonesia Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Remdesivir Market

14.1. South Korea Remdesivir Market Overview
14.2. South Korea Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Remdesivir Market

15.1. Western Europe Remdesivir Market Overview
15.2. Western Europe Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Remdesivir Market

16.1. UK Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Remdesivir Market

17.1. Germany Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Remdesivir Market

18.1. France Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Remdesivir Market

19.1. Italy Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Remdesivir Market

20.1. Spain Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Remdesivir Market

21.1. Eastern Europe Remdesivir Market Overview
21.2. Eastern Europe Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Remdesivir Market

22.1. Russia Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Remdesivir Market

23.1. North America Remdesivir Market Overview
23.2. North America Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Remdesivir Market

24.1. USA Remdesivir Market Overview
24.2. USA Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Remdesivir Market

25.1. Canada Remdesivir Market Overview
25.2. Canada Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Remdesivir Market

26.1. South America Remdesivir Market Overview
26.2. South America Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Remdesivir Market

27.1. Brazil Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Remdesivir Market

28.1. Middle East Remdesivir Market Overview
28.2. Middle East Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Remdesivir Market

29.1. Africa Remdesivir Market Overview
29.2. Africa Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Remdesivir Market Competitive Landscape And Company Profiles

30.1. Remdesivir Market Competitive Landscape
30.2. Remdesivir Market Company Profiles
- 30.2.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BrightGene Bio-Medical Technology Co Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Hainan Haiyao Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sichuan Kelun Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hunan Warrant Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis

31. Remdesivir Market Other Major And Innovative Companies

31.1. Cipla Limited
31.2. Pfizer Inc.
31.3. Merck & Co. Inc.
31.4. Cayman Chemical Company
31.5. Dr. Reddy's Laboratories Ltd.
31.6. Inovio Pharmaceuticals
31.7. Shenzhen BORUI Pharmaceutical Technology Co. Ltd.
31.8. Berry Global Group
31.9. Hetero Labs Limited
31.10. Mylan N.V.
31.11. Jubilant Generics
31.12. Zydus Cadila Health Care Limited
31.13. Syngene International Limited
31.14. Sun Pharmaceutical Industries Ltd.
31.15. Aurobindo Pharma Limited

32. Global Remdesivir Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Remdesivir Market

34. Recent Developments In The Remdesivir Market

35. Remdesivir Market High Potential Countries, Segments and Strategies

35.1 Remdesivir Market In 2029 - Countries Offering Most New Opportunities
35.2 Remdesivir Market In 2029 - Segments Offering Most New Opportunities
35.3 Remdesivir Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer